You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ATI

Showing 1 - 25 of 203
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in Kansas City, Rochester, Saint Louis (ATI-2231, Capecitabine, Denosumab)

Not yet recruiting
  • Metastatic Breast Cancer
  • Kansas City, Kansas
  • +2 more
Mar 16, 2023

Novel Strategies for Personalized Clinical Decisions in Knee

Completed
  • Total Knee Replacement
  • Clinical decision support (CDS) tool
  • Greenville, South Carolina
    ATI Physical Therapy
Jun 9, 2023

Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

Terminated
  • Hepatitis B, Chronic
  • Hepatitis D
  • Chisinau, Republic Of Moldova, Moldova, Republic of
  • +1 more
Nov 15, 2022

HIV Trial in Washington (Antiretroviral Therapy Interruption(ATI))

Enrolling by invitation
  • HIV
  • Antiretroviral Therapy Interruption(ATI)
  • Washington, District of Columbia
  • +1 more
Sep 12, 2022

Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • ATI-450 50mg oral tablet BID
  • +3 more
  • El Cajon, California
  • +24 more
Jan 27, 2023

Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)

Not yet recruiting
  • Chronic HIV Infection
  • 426c.Mod.Core-C4b
  • Adjuvant 3M-052-AF+Alum
  • Birmingham, Alabama
  • +6 more
Aug 17, 2023

Drug Drug Interaction Trial in Montréal (ATI-2173, Midazolam, Clarithromycin)

Completed
  • Drug Drug Interaction
  • Montréal, Quebec, Canada
    Altasciences
Feb 3, 2022

Chronic Hepatitis b Trial in Chisinau, Kyiv (ATI-2173 25mg, Vebicorvir 300mg, Viread 300Mg Tablet)

Terminated
  • Chronic Hepatitis b
  • ATI-2173 25mg
  • +2 more
  • Chisinau, Republic Of Moldova, Moldova, Republic of
  • +1 more
May 25, 2022

Atopic Dermatitis Trial in United States (ATI-1777 2.0% w/w, ATI-1777 1.0% w/w, ATI-1777 0.5% w/w)

Recruiting
  • Atopic Dermatitis
  • ATI-1777 2.0% w/w
  • +3 more
  • Birmingham, Alabama
  • +25 more
Jun 20, 2022

Drug Interaction Trial in Montréal (ATI-2173 50 mg, Tenofovir 300Mg Oral Tablet)

Completed
  • Drug Interaction
  • ATI-2173 50 mg
  • Tenofovir 300Mg Oral Tablet
  • Montréal, Quebec, Canada
    Altasciences
Feb 3, 2022

Psoriatic Arthritis Trial in United States (ATI-450, Placebo Oral Tablet)

Recruiting
  • Psoriatic Arthritis
  • Miami Lakes, Florida
  • +7 more
Aug 19, 2022

Metabolic Associated Fatty Liver Disease in Chinese Population

Completed
  • Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 13, 2022

    Atopic Dermatitis Trial in United States (ATI-1777, Vehicle)

    Completed
    • Atopic Dermatitis
    • Scottsdale, Arizona
    • +13 more
    Mar 10, 2022

    HIV Infection Trial in Brazil, Peru, United States (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Los Angeles, California
    • +11 more
    Jan 13, 2023

    HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1

    Not yet recruiting
    • HIV Vaccine
    • Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
    • +2 more
    • São Paulo, Brazil
      Hospital das Clínicas da Faculdade de Medicina da USP
    Mar 14, 2023

    Addictive Behavior, Substance-Related Disorders Trial in France (Weekly assessment, Weekly assessment ajusted)

    Recruiting
    • Addictive Behavior
    • Substance-Related Disorders
    • Weekly assessment
    • Weekly assessment ajusted
    • Bayonne, France
    • +4 more
    Mar 30, 2022

    HIV Infection Trial in Worldwide (Analytical Treatment Interruption)

    Recruiting
    • HIV Infection
    • Analytical Treatment Interruption
    • Gaborone, Botswana
    • +10 more
    May 16, 2022

    Remimazolam, Awake Endotracheal Intubation Trial in Wuhan (Dos of Afentanil 20, Dos of Afentanil 30, Dos of Afentanil 40)

    Recruiting
    • Remimazolam
    • Awake Endotracheal Intubation
    • Dos of Afentanil 20
    • +8 more
    • Wuhan, Hubei, China
      Tongji Hospital, Tongji Medical College, Huazhong Science and Te
    Aug 30, 2023

    NASH - Nonalcoholic Steatohepatitis, Diabetes, Type 2, Hyperlipidemias Trial in Frankfurt, Mainz (Nutritional Intervention)

    Active, not recruiting
    • NASH - Nonalcoholic Steatohepatitis
    • +2 more
    • Nutritional Intervention
    • Frankfurt, Germany
    • +1 more
    Mar 28, 2022

    Hepatitis B, Chronic Trial in Montréal, Chisinau, Kyiv (ATI-2173, ATI-2173 Placebo)

    Completed
    • Hepatitis B, Chronic
    • Montréal, Quebec, Canada
    • +2 more
    Aug 17, 2021

    Covid19 Trial in Kansas City (ATI-450, Placebo)

    Completed
    • Covid19
    • Kansas City, Kansas
      The University of Kansas Medical Center
    Jun 22, 2021

    Hidradenitis Suppurativa Trial in United States (ATI-450, Placebo oral tablet)

    Recruiting
    • Hidradenitis Suppurativa
    • Birmingham, Alabama
    • +18 more
    Feb 18, 2022

    HIV Trial in Philadelphia (3BNC117-LS, 10-1074-LS)

    Suspended
    • HIV Infections
    • Birmingham, Alabama
    • +5 more
    Jan 31, 2023

    Vaping, Preventive Psychiatry, Social Networking Trial in Rochester (Above the Influence-Vaping (ATI-V))

    Enrolling by invitation
    • Vaping
    • +2 more
    • Above the Influence-Vaping (ATI-V)
    • Rochester, New York
      University of Rochester
    May 9, 2022

    Cryopyrin-Associated Periodic Syndrome Trial in San Diego, San Francisco (ATI-450)

    Terminated
    • Cryopyrin-Associated Periodic Syndrome
    • San Diego, California
    • +1 more
    Mar 26, 2021